Published in Can J Surg on August 01, 2011
Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care (1998) 24.53
Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg (1995) 9.02
Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev (2002) 6.05
Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev (2002) 4.41
Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg (2000) 4.05
Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care (2007) 3.97
Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol (1997) 3.32
Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up. Obes Surg (2000) 3.31
The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg (2006) 2.93
Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr (1992) 2.62
Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care (2002) 2.51
Biliopancreatic diversion with duodenal switch. World J Surg (1998) 2.43
Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab (2004) 2.21
Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res (1999) 2.11
Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes. Diabetes (2007) 1.99
Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. Nat Genet (1996) 1.96
Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci U S A (2000) 1.91
Potential of surgery for curing type 2 diabetes mellitus. Ann Surg (2002) 1.88
Late outcome of isolated gastric bypass. Ann Surg (2000) 1.77
Laparoscopic surgery for morbid obesity. Surg Clin North Am (2001) 1.77
Biliopancreatic diversion for obesity at eighteen years. Surgery (1996) 1.66
Evidence-based medicine: open and laparoscopic bariatric surgery. Surg Endosc (2002) 1.65
Biliopancreatic diversion. World J Surg (1998) 1.64
A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg (1998) 1.61
Update: NIH consensus conference. Gastrointestinal surgery for severe obesity. Nutrition (1996) 1.60
GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg (2006) 1.60
Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg (1999) 1.42
Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab (2002) 1.41
Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis. Diabetes (2007) 1.36
Relief of cardiorespiratory symptoms and increased physical activity after surgically induced weight loss: results from the Swedish Obese Subjects study. Arch Intern Med (2000) 1.34
Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health (2007) 1.32
Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg (1998) 1.20
Bariatric surgery: effects on glucose homeostasis. Curr Opin Clin Nutr Metab Care (2006) 1.09
Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg (1998) 1.07
Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study. J Surg Res (2007) 1.05
Managing type 2 diabetes in France: the ECODIA survey. Diabetes Metab (2000) 1.00
Cost of Type 2 Diabetes mellitus in Hong Kong Chinese. Int J Clin Pharmacol Ther (2007) 0.97
Achievement of near-normal body weight as the prerequisite to normalize sex hormone-binding globulin concentrations in massively obese men. Int J Obes Relat Metab Disord (1997) 0.91
Effects of ileal transposition on food intake, dietary preference, and weight gain in Zucker obese rats. Am J Physiol (1990) 0.88
Impact of bariatric surgery on type 2 diabetes. Cell Biochem Biophys (2007) 0.85
Dipeptidyl peptidase IV inhibition improves impaired glucose tolerance in high-fat diet-fed rats: study using a Fischer 344 rat substrain deficient in its enzyme activity. Jpn J Pharmacol (2002) 0.82
[Glucagon-like peptide-1 (GLP-1), new target for the treatment of type 2 diabetes]. Rev Med Liege (2007) 0.79
Trophic response of gut and pancreas after ileojejunal transposition. Ann Surg (1995) 0.79
Preservation of intestinal structure and function despite weight loss produced by ileal transposition in rats. Physiol Behav (1984) 0.77
Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy. Am J Physiol Heart Circ Physiol (2009) 1.90
Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg (2008) 1.25
Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition. Mol Med (2010) 1.05
Phosphorylation of the human retinoid X receptor alpha at serine 260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands. J Biol Chem (2007) 1.00
Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells. Endocrinology (2003) 0.88
Enhanced stabilization of atherosclerotic plaques in apolipoprotein E-knockout mice by combinatorial Toll-like receptor-1 and -2 gene silencing. Hum Gene Ther (2009) 0.86
Cross talk among Smad, MAPK, and integrin signaling pathways enhances adventitial fibroblast functions activated by transforming growth factor-beta1 and inhibited by Gax. Arterioscler Thromb Vasc Biol (2008) 0.84
Role of aldehyde dehydrogenase 2 Glu504lys polymorphism in acute coronary syndrome. J Cell Mol Med (2011) 0.84
Endoscopic papillary large-balloon dilation following limited sphincterotomy for the removal of refractory bile duct stones: experience of 169 cases in a single Chinese center. J Dig Dis (2013) 0.82
Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death. Int J Nanomedicine (2012) 0.80
Gax gene transfer inhibits vascular remodeling induced by adventitial inflammation in rabbits. Atherosclerosis (2010) 0.79
Influence of estrogen and androgen on the outcome of liver transplantation. Hepatogastroenterology (2008) 0.77
Hepatocyte infusions improve the results of liver transplantation in rats. Hepatogastroenterology (2010) 0.77
Peroxisome proliferator-activated receptor-gamma1 gene therapy attenuates atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice. Hum Gene Ther (2008) 0.76
Hemodialysis-induced hyperglycemia after liver transplantation. Hepatogastroenterology (2009) 0.75
Pro-Inflammation Cytokines: New Potential Therapeutic Targets for Obesity-Related Bone Disorders. Curr Drug Targets (2017) 0.75
Synthesis, chiral resolution, and determination of novel furan lignan derivatives with potent anti-tumor activity. Bioorg Med Chem Lett (2010) 0.75
Management of benign biliary strictures with a novel retrievable self-expandable metal stent. J Dig Dis (2014) 0.75